Novartis AG's cryptocurrency, Novartis AG rStock (RNVS), is a digital asset that represents the company's innovative medicines. The drug pipeline is focused on medical areas such as cardiovascular, immunology, neuroscience, and solid tumors.
The market capitalization of RNVS is approximately ARS 614.01K, with a circulating supply of 2.9 RNVs. This implies that the asset is highly valued by the market.
More on Crypto
Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.
Market sentiment intelligence for apps, funds & agents
Location
729 55 Ave SW
Calgary AB T2V 0G4
Canada
Navigate
© 2026 Guavy Inc
